Dashenlin Pharm Grp Co Ltd (603233) — Capital Reinvestment Ratio
Dashenlin Pharm Grp Co Ltd (603233) has a Capital Reinvestment Ratio of 0.20x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥818.72 Million) in capital expenditures (CN¥161.42 Million). Check Dashenlin Pharm Grp Co Ltd tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Dashenlin Pharm Grp Co Ltd Capital Reinvestment Ratio (2012–2025)
This chart tracks Dashenlin Pharm Grp Co Ltd's Capital Reinvestment Ratio across 14 annual periods. For the full cash flow conversion analysis, see Dashenlin Pharm Grp Co Ltd (603233) cash flow conversion.
Annual Capital Reinvestment Ratio for Dashenlin Pharm Grp Co Ltd (2012–2025)
Year-by-year Capital Reinvestment Ratio for Dashenlin Pharm Grp Co Ltd from 2012 to 2025. See Dashenlin Pharm Grp Co Ltd free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.09x | CN¥5.35 Billion | CN¥484.84 Million | ▼ -80.9% |
| 2024 | 0.48x | CN¥3.11 Billion | CN¥1.48 Billion | ▼ -16.1% |
| 2023 | 0.57x | CN¥3.17 Billion | CN¥1.80 Billion | ▲ +105.5% |
| 2022 | 0.28x | CN¥3.76 Billion | CN¥1.03 Billion | ▼ -66.9% |
| 2021 | 0.83x | CN¥1.55 Billion | CN¥1.29 Billion | ▲ +105.4% |
| 2020 | 0.41x | CN¥1.95 Billion | CN¥792.32 Million | ▲ +38.1% |
| 2019 | 0.29x | CN¥1.71 Billion | CN¥501.41 Million | ▼ -53.7% |
| 2018 | 0.63x | CN¥873.64 Million | CN¥554.39 Million | ▼ -39.2% |
| 2017 | 1.04x | CN¥640.39 Million | CN¥668.53 Million | ▲ +68.3% |
| 2016 | 0.62x | CN¥495.60 Million | CN¥307.35 Million | ▲ +17.3% |
| 2015 | 0.53x | CN¥468.59 Million | CN¥247.84 Million | ▼ -9.4% |
| 2014 | 0.58x | CN¥448.58 Million | CN¥261.82 Million | ▼ -53.8% |
| 2013 | 1.26x | CN¥288.22 Million | CN¥363.99 Million | ▲ +510.4% |
| 2012 | 0.21x | CN¥289.31 Million | CN¥59.85 Million | — |